Mozart Therapeutics, the leading developer of CD8 Treg network modulators in autoimmune disease, announces the presentation ...

Revenue in Q4 2024 increased 45% to $13.53 billion driven by volume growth from Mounjaro and Zepbound. Non-incretin revenue(i) grew by 20% compared to Q4 2023. Pipeline ...

Researchers discovered a previously unknown mechanism that may drive tissue damage and a new target for drug discovery.

· The burden of both hypothyroidism and anaemia is on the rise. Anaemia amongst women between 15 and 49 years increased from ...

Harvard researchers have found that M. morganii may contribute to depression by producing an inflammatory molecule.